Literature DB >> 28177764

Potential regulatory mechanisms of lncRNA in diabetes and its complications.

Shui-Dong Feng1, Ji-Hua Yang2, Chao Hua Yao3, Si-Si Yang2, Ze-Mei Zhu2, Di Wu2, Hong-Yan Ling2, Liang Zhang3.   

Abstract

Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides without protein-coding potential. Although these molecules were initially considered as "junk products" of transcription without biological relevance, recent advances in research have shown that lncRNA plays an important role, not only in cellular processes such as proliferation, differentiation, and metabolism, but also in the pathological processes of cancers, diabetes, and neurodegenerative diseases. In this review, we focus on the potential regulatory roles of lncRNA in diabetes and the complications associated with diabetes.

Entities:  

Keywords:  complications diabétiques; diabetes; diabetic complications; diabète; lncRNA; longs ARNnc

Mesh:

Substances:

Year:  2016        PMID: 28177764     DOI: 10.1139/bcb-2016-0110

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  24 in total

1.  Long non-coding RNA LINC00673 promotes hepatocellular carcinoma progression and metastasis through negatively regulating miR-205.

Authors:  Li-Guo Zhang; Xin-Ke Zhou; Ru-Jian Zhou; Hui-Zeng Lv; Wei-Peng Li
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

Review 2.  Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus.

Authors:  Weiyue Zhang; Juan Zheng; Xiang Hu; Lulu Chen
Journal:  Endocrine       Date:  2019-07-25       Impact factor: 3.633

3.  Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus.

Authors:  Leyla Saeidi; Hamid Ghaedi; Mirsaber Sadatamini; Rouhollah Vahabpour; Ali Rahimipour; Mehrnoosh Shanaki; Zahra Mansoori; Faranak Kazerouni
Journal:  Mol Biol Rep       Date:  2018-10-16       Impact factor: 2.316

4.  Inhibition of long non-coding RNA TUG1 protects against diabetic cardiomyopathy induced diastolic dysfunction by regulating miR-499-5p.

Authors:  Lei Zhao; Weiguo Li; Hao Zhao
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

5.  Downregulation of long non-coding RNAs LINC00523 and LINC00994 in type 2 diabetes in an Iranian cohort.

Authors:  Zahra Mansoori; Hamid Ghaedi; Mirsaber Sadatamini; Rouhollah Vahabpour; Ali Rahimipour; Mehrnoosh Shanaki; Leyla Saeidi; Faranak Kazerouni
Journal:  Mol Biol Rep       Date:  2018-07-24       Impact factor: 2.316

6.  Inhibition of lncRNA Dlx6os1 decreases cell proliferation and fibrosis and increases cell apoptosis in diabetic nephropathy.

Authors:  Jie Cheng; Li Cheng; Yubin Tang; Huihua Li; Wenfang Peng; Shan Huang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

7.  Deregulation of lncRNA HIST1H2AG-6 and AIM1-3 in peripheral blood mononuclear cells is associated with newly diagnosed type 2 diabetes.

Authors:  Hui Jiang; Peian Lou; Xiaoluo Chen; Chenguang Wu; Shihe Shao
Journal:  BMC Med Genomics       Date:  2021-06-06       Impact factor: 3.063

Review 8.  EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress.

Authors:  Roberta Giordo; Yusra M A Ahmed; Hilda Allam; Salah Abusnana; Lucia Pappalardo; Gheyath K Nasrallah; Arduino Aleksander Mangoni; Gianfranco Pintus
Journal:  Front Cell Dev Biol       Date:  2021-05-19

9.  Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.

Authors:  Daojun Hu; Boke Zhang; Miao Yu; Wenjie Shi; Li Zhang
Journal:  Mol Med Rep       Date:  2020-05-22       Impact factor: 2.952

10.  MALAT1 Regulated mTOR-Mediated Tau Hyperphosphorylation by Acting as a ceRNA of miR144 in Hippocampus Cells Exposed to High Glucose.

Authors:  Chong Lu; Yikui Zhao; Yan Cao; Li Liu; Shanshan Wu; Dongbin Li; Shuang Liu; Shuyuan Xiao; Yafen Wei; Xinyu Li
Journal:  Clin Interv Aging       Date:  2021-06-22       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.